CHEK1 and cancer: In the absence of p53, however, cells become highly dependent on CHK1 for cell cycle control, arrest, and repair of DNA damage 12, 14, generating a vulnerability that is currently explored as a means to treat cancers with CHK1 inhibitors 11, 20.